Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.54	71.55	23.87	27.27	28.02	31.81
Cash & Short-Term Investments	60.54	71.55	23.87	27.27	28.02	31.81
Cash Growth	-32.64%	199.71%	-12.47%	-2.68%	-11.89%	-35.52%
Accounts Receivable	11.86	7.34	8.47	4.7	12.12	6.96
Receivables	11.86	7.34	8.47	4.7	12.12	6.96
Inventory	8.13	6.04	6.77	5.78	4.04	2.46
Prepaid Expenses	1.2	3.29	1.85	2.13	3.08	3.4
Total Current Assets	81.72	88.22	40.97	39.89	47.26	44.63
Property, Plant & Equipment	8.77	8.98	9.74	9.3	7.78	10.32
Other Intangible Assets	-	-	1.28	1.44	0.05	0.1
Other Long-Term Assets	3.21	4.22	5.44	6.45	6.9	7.84
Total Assets	93.7	101.42	57.42	57.07	61.99	62.88
Accounts Payable	11.95	10.29	8.93	9.95	8.31	7.09
Accrued Expenses	5.37	5.99	6.5	7.97	8.74	8.57
Current Portion of Long-Term Debt	3.18	0.03	0.02	18.7	2.03	2.58
Current Portion of Leases	0.57	0.51	0.39	0.26	0.9	0.73
Current Unearned Revenue	2.09	2.05	2.47	2.66	1.99	2.14
Total Current Liabilities	23.16	18.87	18.31	39.53	21.96	21.1
Long-Term Debt	31.71	32.35	27.34	33.45	51.55	34.33
Long-Term Leases	4.8	5.11	5.57	5.09	1.95	2.85
Long-Term Unearned Revenue	81.86	82.72	95.91	95.53	66.18	51.16
Other Long-Term Liabilities	24.76	22.52	16.78	2.03	2.49	1.95
Total Liabilities	166.29	161.58	163.91	175.62	144.13	111.38
Common Stock	0.1	0.09	0.07	0.06	0.04	0.04
Additional Paid-In Capital	327	302.97	212.52	192.6	174.62	137.73
Retained Earnings	-399.69	-363.21	-319.08	-311.21	-256.8	-186.26
Total Common Equity	-72.59	-60.16	-106.49	-118.55	-82.13	-48.5
Shareholders' Equity	-72.59	-60.16	-106.49	-118.55	-82.13	-48.5
Total Liabilities & Equity	93.7	101.42	57.42	57.07	61.99	62.88
Total Debt	40.26	38	33.32	57.49	56.42	40.48
Net Cash (Debt)	20.28	33.54	-9.45	-30.22	-28.4	-8.67
Net Cash Per Share	0.22	0.39	-0.15	-0.62	-0.75	-0.26
Filing Date Shares Outstanding	99.72	98.87	73.3	55.87	41.47	36.21
Total Common Shares Outstanding	99.35	91.41	68.53	54.83	41.23	34.57
Working Capital	58.57	69.36	22.66	0.36	25.3	23.52
Book Value Per Share	-0.73	-0.66	-1.55	-2.16	-1.99	-1.40
Tangible Book Value	-72.59	-60.16	-107.77	-119.99	-82.19	-48.6
Tangible Book Value Per Share	-0.73	-0.66	-1.57	-2.19	-1.99	-1.41
Machinery	23.98	23.77	23.64	23.21	22.49	25.54
Construction In Progress	2.22	2.11	2.03	1.47	1.16	0.88
Leasehold Improvements	21.42	21.42	21.39	21.38	21.27	21.33

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q